Zhu X - Search Results

1

Preclinical evaluation of radiolabeled tissue factor-targeted peptide for theranostics of hepatocellular carcinoma post percutaneous ethanol injection.

Zhang B, Wang P, Chen Q, Yang Y, Xiong F, Bao G, Yang J, Wang Z, Zhou H, Song S, Zou S, Kim DH, Yu B, Zhu X. Zhang B, et al. Among authors: zhu x. Theranostics. 2024 Oct 28;14(19):7370-7382. doi: 10.7150/thno.102130. eCollection 2024. Theranostics. 2024. PMID: 39659572 Free PMC article.

2

Novel Glypican-3-Binding Peptide for in Vivo Hepatocellular Carcinoma Fluorescent Imaging.

Zhu D, Qin Y, Wang J, Zhang L, Zou S, Zhu X, Zhu L. Zhu D, et al. Among authors: zhu x, zhu l. Bioconjug Chem. 2016 Mar 16;27(3):831-9. doi: 10.1021/acs.bioconjchem.6b00030. Epub 2016 Feb 19. Bioconjug Chem. 2016. PMID: 26850086

3

Elevated 68Ga-DOTATATE Activity in IgG4-Related Lymphadenopathy.

Cheng Z, Song S, Han Y, Zou S, Zhu X. Cheng Z, et al. Among authors: zhu x. Clin Nucl Med. 2018 Oct;43(10):773-776. doi: 10.1097/RLU.0000000000002223. Clin Nucl Med. 2018. PMID: 30059434

4

Telbivudine-Induced Myopathy Incidentally Detected by FDG PET/CT Imaging in a Patient With History of Hepatocellular Carcinoma.

Zou S, Cheng Z, Song S, Zhu D, Zhu X. Zou S, et al. Among authors: zhu d, zhu x. Clin Nucl Med. 2019 Feb;44(2):171-172. doi: 10.1097/RLU.0000000000002385. Clin Nucl Med. 2019. PMID: 30608913

5

Concurrent Metastatic Pheochromocytomas and Lung Adenocarcinoma on 18F-FDG and 68Ga-DOTATATE PET/CT Images.

Cheng Z, Zou S, Song S, Zhu X. Cheng Z, et al. Among authors: zhu x. Clin Nucl Med. 2019 Sep;44(9):754-756. doi: 10.1097/RLU.0000000000002588. Clin Nucl Med. 2019. PMID: 31021913

6

Monitoring the Response of PD-L1 Expression to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Nonsmall-Cell Lung Cancer Xenografts by Immuno-PET Imaging.

Li D, Zou S, Cheng S, Song S, Wang P, Zhu X. Li D, et al. Among authors: zhu x. Mol Pharm. 2019 Aug 5;16(8):3469-3476. doi: 10.1021/acs.molpharmaceut.9b00307. Epub 2019 Jul 8. Mol Pharm. 2019. PMID: 31283253

7

FDG PET/CT of COVID-19.

Zou S, Zhu X. Zou S, et al. Among authors: zhu x. Radiology. 2020 Aug;296(2):E118. doi: 10.1148/radiol.2020200770. Epub 2020 Mar 6. Radiology. 2020. PMID: 32142399 Free PMC article. No abstract available.

8

The development of a Glypican-3-specific binding peptide using in vivo and in vitro two-step phage display screening for the PET imaging of hepatocellular carcinoma.

Qin Y, Cheng S, Li Y, Zou S, Chen M, Zhu D, Gao S, Wu H, Zhu L, Zhu X. Qin Y, et al. Among authors: zhu d, zhu x, zhu l. Biomater Sci. 2020 Oct 13;8(20):5656-5665. doi: 10.1039/d0bm00943a. Biomater Sci. 2020. PMID: 32896851

9

Comparison of 18F-FDG, 68Ga-FAPI, and 68Ga-DOTATATE PET/CT in a Patient With Pancreatic Neuroendocrine Tumor.

Cheng Z, Zou S, Cheng S, Song S, Zhu X. Cheng Z, et al. Among authors: zhu x. Clin Nucl Med. 2021 Sep 1;46(9):764-765. doi: 10.1097/RLU.0000000000003763. Clin Nucl Med. 2021. PMID: 34132674

10

Positive FAPI PET/CT in a Bilateral Mammary Angiosarcoma Patient With Less Impressive FDG PET/CT Images.

Qiu S, Zou S, Cheng S, Song S, Zhu X. Qiu S, et al. Among authors: zhu x. Clin Nucl Med. 2022 Jul 1;47(7):648-650. doi: 10.1097/RLU.0000000000004089. Epub 2022 Feb 10. Clin Nucl Med. 2022. PMID: 35143460

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39,854 results

Search Page

Filters